Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.04-1.53 (-3.59%)
At close: 04:00PM EST
41.05 +0.01 (+0.02%)
Pre-market: 04:00AM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-392,990
-351,511
-225,334
-152,142
Depreciation & amortisation
5,418
4,903
2,731
397
Stock-based compensation
54,566
38,780
23,941
10,521
Change in working capital
15,025
28,064
15,541
17,707
Accounts payable
-3,241
-763
7,278
1,417
Other working capital
-335,719
-297,141
-189,049
-136,694
Other non-cash items
5,420
-6,874
672
2,445
Net cash provided by operating activities
-332,359
-293,187
-178,546
-117,802
Cash flows from investing activities
Investments in property, plant and equipment
-3,360
-3,954
-10,503
-18,892
Purchases of investments
-722,702
-887,737
-425,158
0
Sales/maturities of investments
923,260
502,857
0
-
Net cash used for investing activities
197,198
-388,834
-435,661
-18,892
Cash flows from financing activities
Common stock issued
-57
238,263
328,251
0
Other financing activities
30,964
37,102
30,895
440,835
Net cash used provided by (used for) financing activities
42,375
623,191
423,602
440,835
Net change in cash
-92,786
-58,830
-190,605
304,141
Cash at beginning of period
250,467
197,218
387,823
83,682
Cash at end of period
157,681
138,388
197,218
387,823
Free cash flow
Operating cash flow
-332,359
-293,187
-178,546
-117,802
Capital expenditure
-3,360
-3,954
-10,503
-18,892
Free cash flow
-335,719
-297,141
-189,049
-136,694